Views & Analysis Harmonised health technology assessment in Europe? There's a... Europe is heading towards harmonisation in health technology assessment – but great differences remain in practices and culture
Market Access Row over CF drug funding as NHS rejects Vertex offer Vertex 'astonished and dismayed' by NHS rejection
Views & Analysis Need for leaders as Value & Access plays increasing role in ... Ana Céspedes, senior vice president of global marketing and strategy at EMD Serono, on the evolution of the Value & Access function.
Views & Analysis Medical technology and digital: primary levers for change What steps can traditional pharma and medtech companies take to update their processes to support a move to more agile, digital business models?
Debates & Insight Sponsored Pricing and Market Access Outlook 2018 This year’s edition of Pricing and Market Access Outlook, our first as IQVIA, identifies a trend towards models that reward value and outcomes.
News Ipsen' Bylvay fluffs its lines in biliary atresia trial Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.